New AACE 2025 Dyslipidemia Management Guidelines Released – Top 7 Takeaways Nidhi Srivastava19 Feb 2025 2:52 PM ISTOhio: The 2025 American Association of Clinical Endocrinology (AACE) guidelines offer evidence-based recommendations for the pharmacologic management...
CDSCO panel Rejects Akum Pharma's FDC Bempedoic acid plus Atorvastatin Calcium plus Ezetimibe Dr. Divya Colin11 March 2024 6:00 PM ISTNew Delhi: Reviewing the justification presented by the drug major Akum Pharmaceutical with respect to the triple-drug combination of Bempedoic acid...
Bempedoic Acid Significantly Reduces Total Cardiovascular Events, Study Finds Dr.Niharika Harsha B2 Feb 2024 10:30 AM ISTIn a groundbreaking development, the Cholesterol Lowering via Bempedoic Acid, an ACL-Inhibiting Regimen (CLEAR) Outcomes trial has unveiled a novel...
Esperion, Daiichi Sankyo Europe announce USD 125 million amendment to their collaboration, including resolution of pending litigation Ruchika Sharma4 Jan 2024 4:45 PM ISTAnn Arbor: Esperion Therapeutics, Inc. and Daiichi Sankyo Europe GmbH (DSE), the European headquarter organization of the Japanese pharmaceutical...
Bempedoic acid use not tied to increased risk of new-onset diabetes: CLEAR Outcomes analysis Medha Baranwal24 Dec 2023 10:15 PM ISTUSA: Bempedoic acid safely reduces LDL cholesterol levels and the risk of cardiovascular events in statin-intolerant patients with and without...
Novel hypolipidemic bempedoic acid safe in diabetics, may overcome shortcomings of statins: Lancet dr. Abhimanyu Uppal13 Dec 2023 6:30 PM ISTStatins reduce LDL cholesterol and cardiovascular events among those with or without diabetes but have been reported to increase new-onset diabetes. A...
Modify phase IV CT Protocol: CDSCO panel Tells Akums Pharma on FDC Bempedoic acid, Rosuvastatin Calcium Dr. Divya Colin26 Nov 2023 5:45 PM ISTNew Delhi: After reviewing the Phase IV clinical trial protocol of the fixed-dose combination Bempedoic acid plus Rosuvastatin Calcium presented by...
CDSCO Panel Tells Akums to submit rationale for FDC Bempedoic acid, Atorvastatin, Ezetimibe film-coated tablet Dr. Divya Colin23 Sept 2023 6:00 PM ISTNew Delhi: Responding to the proposal presented by the drug major Akum Pharmaceuticals regarding the fixed-dose combination drug containing Bempedoic...
Clear cardiovascular benefit with bempedoic acid revealed in two studies Dr. Kamal Kant Kohli12 Sept 2023 8:00 PM ISTUSA: Analysis of the CLEAR Outcomes trial results revealed the totality of the benefit of bempedoic acid on cardiovascular risk reduction, not just...
Bempedoic acid effective in reducing MI risk among statin-intolerant patients with hyperlipidemia Dr. Kamal Kant Kohli7 Aug 2023 11:00 AM ISTAustria: A recent review published in European Heart Journal - Cardiovascular Pharmacotherapy has shed light on cardiovascular (CV) events in patients...
Bempedoic acid tied to primary prevention of cardiovascular events in statin-intolerant patients: JAMA Medha Baranwal27 Jun 2023 11:45 AM ISTUSA: Results from a randomized trial of 13 970 patients revealed that treatment with bempedoic acid could potentially reduce major adverse...
Bempedoic acid improves cardiovascular outcomes in statin-intolerant patients, CLEAR Outcomes trial dr. Abhimanyu Uppal4 May 2023 11:00 AM ISTBempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of...
